NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs041190078

Registered date:14/11/2019

Intraoperative fluorescein angiography using an ophthalmic endoscope

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedDiabetic retinopathy. Uveitis. Age-related macular degeneration. Rubeotic glaucoma.
Date of first enrollment14/11/2019
Target sample size40
Countries of recruitment
Study typeInterventional
Intervention(s)Evaluate the presence or absence of neovacular and non perfusion area between the preoperative fluorescein angiography (FA) images and the intraoperative endoscopic FA images by using the findings score.

Outcome(s)

Primary OutcomeEvaluate the presence or absence of neovacular and non perfusion area between the preoperative fluorescein angiography (FA) images and the intraoperative endoscopic FA images by using the findings score.
Secondary OutcomeSafety of the intraoperative endoscopic fluoresein angiography test.

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum< 85age old
GenderBoth
Include criteriaPatients who sufficiently understand this study, agree to participate in this study after receiving sufficient explanation and obtain written informed consent under their own will. Patients older than 20 and under 85 years old at the time of informed consent acquisition. Patients whose blood circulation evaluation by intraoperative fluorescein angiography (FA) using an ophthalmic endoscope are thought to be useful, and who require intraocular surgery. Specifically, the following patients. Patients with difficulty in evaluating the fundus with normal FA test due to small pupil, severe cataract, vitreous hemorrhage or vitreous opacity. Or patients who may have neovascular or non perfusion area in the peripheral retina, under the retina, at the back of the iris, or at angle that can not be visualized by normal FA test, subjects are shown below. - Diabetic retinopathy - Uveitis - Familial exudative vitreoretinopathy - Retinal detachment secondary to atopic dermatitis, uveitis or retinal vein occlusion - Age related macular degeneration - Neovascular glaucoma - Secondary glaucoma
Exclude criteriaPatients who previously examined FA test and have experienced adverse reactions or poor physical condition due to contrast media. Patients who previously had severe food or drug allergies. Patients who have severe hepatic dysfunction. Patients who have severe hypertension (grade III hypertension). Pregnant woman, maternal, lactating woman. Patients who show the following abnormalities in screening tests. - Systolic blood pressure is higher than 180 mmHg or diastolic blood pressure is more than 120 mmHg. - AST or ALT is higher than 100 IU/L. Patients who are considered inappropriate to participate in this study by the principal investigator or subinvestigator.

Related Information

Contact

Public contact
Name Sho Yokoyama
Address 1-1-10 Sanjo, Minami-ku, Nagoya city, Aichi Aichi Japan 457-8510
Telephone +81-52-691-7151
E-mail yokoyama@chukyogroup.jp
Affiliation Japan Community Health care Organization Chukyo Hospital
Scientific contact
Name Tatsushi Kaga
Address 1-1-10 Sanjo, Minami-ku, Nagoya city, Aichi Aichi Japan 457-8510
Telephone +81-52-691-7151
E-mail kaga@sanjogroup.jp
Affiliation Japan Community Health care Organization Chukyo Hospital